International Clinical Trial: Effectiveness and durability of ready-to-use botulinum toxin A formulations (Relfydess and Alluzience) for treating moderate to severe frown lines: a randomized controlled clinical trial

Geneva, May 4 -- International Clinical Trials Registry received information related to the study (RBR-10tkjh3t) titled 'Effectiveness and durability of ready-to-use botulinum toxin A formulations (Relfydess and Alluzience) for treating moderate to severe frown lines: a randomized controlled clinical trial' on April 26.

Study Type: Intervention

Study Design: 3, randomized-controlled, triple-blind

Primary Sponsor: Centro Universitario Uninga

Condition: Facial Muscles Skin Aging G07.345.124

Intervention: This study is designed as a randomized, controlled, two-arm, triple-blind clinical trial, in which participants, the injector, and the outcome assessor are all blinded to group allocation. A total of 40 female participants aged bet...